Waxman Compromise Bill Clears House; Centers Line Item Traded For Guarantee Of Minimum Number of 55
In Brief: NCAB to Hear Program Review, Reports On AIDs Monoclonal Antibodies, Cancer Research at Drew
DRG Regulation Opponents May Have Powerful New Ally
DRCCA Staff Boom To 145, Still Growing, Still Looking for People
SSO Education Group Lists “Major Unmet Needs, Problems”
RFA On Breast Cancer Low Fat Diet Available
Trending Stories
- DOD cancer research programs face 57% funding cut in year-long continuing resolution
Pancreatic, lung, kidney cancer research programs eliminated - Kennedy announces massive cuts, centralization at HHS—NCI and FDA hit
Also this week: Columbia yields, Makary and Bhattacharya confirmed, tariffs on pharmaceuticals, and more changes impacting oncology - What Trump’s pick of RFK Jr. means for cancer: Epidemics, HPV, stunted research
Former FDA Commissioner Scott Gottlieb expresses “deep concerns” - Jonathan Friedberg tells us how he built a cancer center in an underserved area of New York State
- Breast cancer activists in the 90s got DOD to fund cancer research—now that program has been gutted
- In The Headlines: HHS shakeup threatens a legacy of medical breakthroughs